PMA device
Freestyle Libre Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE, Class III) · First FDA decision Sep 27, 2017, newest May 6, 2019Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
66
Naming "Freestyle Libre Flash"
MAUDE reports
10
Brand "Freestyle Libre Flash", since 2015
PubMed studies
84
Mentioning "Freestyle Libre Flash"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Freestyle Libre Flash Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Freestyle Libre Flash Glucose Monitoring SystemPMA supplement
P160030-S031 · Decided May 6, 2019 · 98 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated (PZE) · Laboratory Medicine & Pathology
- Freestyle Libre Flash Glucose Monitoring SystemPMA supplement
P160030-S014 · Decided Jul 23, 2018 · 133 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated (PZE) · Laboratory Medicine & Pathology
- Freestyle Libre Flash Glucose Monitoring System; FreeStyle Libre 14 Day Flash Glucose Monitoring SystemPMA supplement
P160030-S010 · Decided Oct 31, 2018 · 247 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated (PZE) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Freestyle Libre Flash", any status and sponsor, newest update first.
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose MonitoringActive, not recruiting
Shanghai 6th People's HospitalAcademic, hospital or other
NCT06863337 · 100 participants (planned) · Start Mar 26, 2025 · Primary completion Jun 30, 2026
Device: CGM · For: Infertility Female
Sites: Shanghai, China
University of NebraskaAcademic, hospital or other
NCT05766488 · 0 participants · Start Jul 23, 2023 · Primary completion Jul 20, 2026
Device: Continuous Glucose Monitor (CGM); Self-monitoring Blood Glucose (SMBG) · For: Type 2 Diabetes
Sites: Omaha, Nebraska
IMDEA FoodAcademic, hospital or other
NCT07626658 · 471 participants (planned) · Start Oct 15, 2026 · Primary completion May 2028
Device: Continuous glucose monitoring using a wearable sensor (flash interstitial glucose monitor) · For: Prediabetes (Insulin Resistance, Impaired Glucose Tolerance); Artificial Intelligence Mobile Application
Sites: Madrid, Spain
63 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Freestyle Libre Flash", and for the whole product code for context.
This brand
10 reports: 3 malfunction, 7 injury, 0 death
Whole product code PZE
143,343 reports: 125,788 malfunction, 17,533 injury, 14 death
Newest reports for this brand
- FREESTYLE LIBRE FLASH GLUCOSE READERMalfunction
MW5117197 · Received May 1, 2023 · Event dated Apr 14, 2023
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)
Device problem as coded: Overheating of Device
Patient problem as coded: Insufficient Information
MW5094076 · Received Apr 7, 2020 · Event dated Feb 1, 2020 · 2 other devices named on this report
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Loose or Intermittent Connection; Detachment of Device or Device Component
Patient problem as coded: Rash; Fluid Discharge
MW5091972 · Received Dec 31, 2019 · Event dated Dec 24, 2019 · 5 other devices named on this report
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Loss of or Failure to Bond; Defective Component
Patient problem as coded: No Known Impact Or Consequence To Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- FreeStyle Libre Reader, REF: 71525-01, 71701-01, 71739-01 a component of the FreeStyle Libre Flash Glucose Monitoring SystemOpen, Classified
Z-1273-2023 · Started Feb 13, 2023 · Posted by FDA Apr 6, 2023
Reason given: Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it is damaged, cracked, swelling, too hot to hold, it will no longer hold charge, or it fails Reader Test. Do not use other...
Cause as FDA categorized it: Device Design · Device type: Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)
Published research
The most relevant PubMed records for "Freestyle Libre Flash"[tiab]. The summary above synthesizes these.
- Accuracy of FreeStyle Libre flash glucose monitoring in patients with type 2 diabetes who migrated from highlands to plains.
Sun ZM, Du YZ, Wang SY, et al. · World J Diabetes · 2024
- Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
Lameijer A, Fokkert MJ, Edens MA, et al. · J Clin Transl Endocrinol · 2020
- FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.
Blissett R, Blissett D, Levrat-Guillen F, et al. · BMJ Open Diabetes Res Care · 2022Research Support, Non-U.S. Gov't
- FreeStyle Libre flash glucose monitoring system in pregnant woman with type 1 diabetes: a focus on accuracy.
Gatti M, Amato AML, Bruttomesso D · Acta Diabetol · 2019Letter
- Performance of the FreeStyle Libre Flash Glucose Monitoring System during an Oral Glucose Tolerance Test and Exercise in Healthy Adolescents.
Afeef S, Tolfrey K, Zakrzewski-Fruer JK, et al. · Sensors (Basel) · 2023
- Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals.
Pintus D, Ng SM · Diabetes Metab Syndr · 2019
- Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study.
Canecki Varzic S, Steiner K, Gradinjan Centner M, et al. · Diagnostics (Basel) · 2021
- Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile.
Palacios A, Rodriguez Cairoli F, Balan D, et al. · Expert Rev Pharmacoecon Outcomes Res · 2023
- The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK.
Yadegarfar G, Anderson SG, Khawaja Z, et al. · Cardiovasc Endocrinol Metab · 2020
- Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system.
Ajjan RA, Cummings MH, Jennings P, et al. · Diab Vasc Dis Res · 2019Review
- Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina.
Palacios A, Rodriguez-Cairoli F, Balan D, et al. · Appl Health Econ Health Policy · 2023
Other devices of this type
Also filed under product code PZE.
- FreeStyle Libre 14 day Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2024
- Freestyle Libre ProAbbott Diabetes Care, Inc. · PMA 2019
- FreeStyle Libre 14-day Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.